Figure 4.

Cell viability of SKOV3 cells treated with Cisplatin. (a) Cell proliferation was assessed using the MTT method on SKOV3^shScr and SKOV3^shFHC cells treated with Cisplatin at the indicated doses. Final results represent mean ± SD of three independent experiments each performed in triplicate (* p < 0.05; n.s., not significant, p ≥ 0.05). (b) Cell proliferation was assessed using the MTT method on SKOV3^{shFHC/pRc/CMV} and SKOV3^{shFHC/Rc/CMV-HA-IκBα} cells treated with Cisplatin at the indicated doses and transfected with IκBα. Final results represent mean ± SD of three independent experiments each performed in triplicate (n.s., not significant, p ≥ 0.05).